Antoine de Lachaux

Antoine de Lachaux currently serves as Head of Unit and previously as Investment Officer in the Life Science sector at the European Investment Bank (EIB) since March 2015. In these roles, Antoine de Lachaux leads investment processes in SMEs, focusing primarily on the life sciences. Additionally, Antoine de Lachaux has taken on multiple investor roles with significant investments in various companies, including EUR 25 million in Germitec, EUR 40 million in Cellectis, EUR 10.6 million in Carthera, EUR 50 million in Inventiva Pharma, EUR 20 million in Stilla Technologies, and EUR 15 million in both Quantum Surgical SAS and eCential Robotics. Other notable investments include EUR 30 million in Quantum Surgical SAS and EUR 10 million in XENOTHERA.